Loading organizations...
§ Private Profile · Sweden
Digital therapeutics company developing Joint Academy, an app-based platform for physical therapy and education for osteoarthritis.
Arthro has raised $33.0M across 4 funding rounds.
Key people at Arthro.
Arthro has raised $33.0M in total across 4 funding rounds.
Arthro Therapeutics, operating as Joint Academy, is a Malmö, Sweden-based digital health company that develops a software-as-a-medicine platform connecting patients with licensed physical therapists for osteoarthritis treatment. The platform integrates directly into national electronic health records to deliver individualized exercise programs, patient education, and progress tracking through a smartphone application. The company operates a B2B2C model, securing partnerships with major healthcare providers and government agencies including Capio Sweden, Volvat Norway, and Apoteket AB. Arthro has facilitated care for over 150,000 patients globally through a network of more than 600 physical therapists operating on its system. The firm has raised over $30 million in total venture funding, including a $22.5 million Series B round led by Kinnevik, alongside investments from Alfvén & Didriksson. Arthro was founded in 2014 by Jakob Dahlberg and Leif Dahlberg.
Key people at Arthro.
Arthro has raised $33.0M in total across 4 funding rounds.
Arthro's investors include Kinnevik, Fifth Wall, Maveron, Norwest Venture Partners, Justin Mateen, Matt Mazzeo, Karl-Johan Persson, Alfv n & Didrikson, Cherry Ventures, CrunchFund, Vidu Shanmugarajah, Heartcore Capital.
Arthro has raised $33.0M across 4 funding rounds. Most recently, it raised $23.0M Joint Academy - Series B in September 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 1, 2020 | $23M Series B | Kinnevik | Fifth Wall, Maveron, Norwest Venture Partners, Justin Mateen, Matt Mazzeo, Karl Johan Persson, Alfv N & Didrikson | Announced |
| Sep 12, 2018 | $7M Series A | Alfv N & Didrikson | — | Announced |
| Dec 1, 2016 | $2M Seed | — | Cherry Ventures, CrunchFund, Vidu Shanmugarajah, Heartcore Capital, Kearny Jackson, Look UP Ventures, Partech Ventures, Sweet Capital, Techstars, John Bonten, Marcelo Sampaio | Announced |
| May 1, 2016 | $1M Seed | — | Cherry Ventures, Vidu Shanmugarajah, Kearny Jackson, Partech Ventures, Techstars, John Bonten, Marcelo Sampaio | Announced |
Arthro Therapeutics is a Swedish healthcare startup founded in 2014, specializing in software-as-a-medicine for osteoarthritis treatment. Its flagship product, Joint Academy, uses clinically evidenced, data-driven digital therapeutics to diagnose and manage the chronic condition, targeting patients beyond traditional pills and surgery. Serving individuals with osteoarthritis, Swedish government entities, and major insurance companies, it addresses gaps in accessible, non-invasive care for a disease affecting millions, with a small team of 1-10 employees focused on healthcare SaaS and life sciences[2].
The company emphasizes real science from experts including professors, physiotherapists, engineers, and venture capital partners, positioning it as a pioneer in digital health for joint health. While early-stage with undisclosed funding details, its government and insurer clients indicate steady traction in a growing digital therapeutics market[2].
Arthro Therapeutics emerged in 2014 in Sweden, driven by a team of industry experts rethinking osteoarthritis care. The idea stemmed from recognizing limitations in conventional treatments—pills and surgery—for hard-to-treat cases, leading to the creation of Joint Academy as an evidence-based digital platform. Key contributors include professors, physiotherapists, engineers, and venture capital from specialized firms, blending clinical expertise with technology[2].
Early traction came from securing the Swedish government and major insurance companies as customers, validating its model amid rising demand for scalable, objective-data-driven healthcare solutions. This foundation has sustained its focus on transforming diagnosis and treatment for osteoarthritis[2].
Arthro Therapeutics rides the digital therapeutics and software-as-a-medicine wave, capitalizing on trends in personalized, non-pharmacological healthcare amid rising osteoarthritis prevalence due to aging populations and sedentary lifestyles. Timing aligns with post-pandemic acceleration in telehealth and AI-driven diagnostics, where objective data fills gaps in traditional orthopedics[2].
Market forces like insurer adoption and government backing favor scalable SaaS solutions, reducing surgery burdens in a $100B+ global osteoarthritis market. By influencing ecosystems through evidence-based tools, it pioneers hybrid clinician-patient models, potentially expanding to other chronic joint conditions and inspiring similar ventures in Europe[2].
Arthro Therapeutics is poised for expansion by deepening insurer partnerships and scaling Joint Academy internationally, leveraging its clinical evidence to penetrate larger markets like the US and EU. Trends in AI-enhanced diagnostics, regulatory nods for digital therapeutics, and value-based care will propel growth, potentially attracting Series A/B funding for team buildup and feature enhancements like predictive analytics.
As digital health matures, its influence could evolve from niche osteoarthritis leader to broader musculoskeletal platform, challenging incumbents by proving software's efficacy in chronic disease management—echoing its founding mission to transform care beyond conventional limits[2].
